AstraZeneca will pay nearly a half-billion dollars to settle cases alleging its popular heartburn drugs damages the kidneys of users. The Cambridge, UK-based pharma giant will be paying $425 ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...

Hyperkalemia (HK) is a chronic condition characterised by high levels of potassium in the blood. The Anglo-Swedish drugmaker ...

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is ...